Perioperative Inflammatory Cytokine Profiles in Patients with Atrial Fibrillation Undergoing Catheter Treatment: A

Kenzhebek Bizhanov1,2, Adil Baimbetov1, Alexander Sapunov1

  • 1Department of Interventional Cardiology, Arrhythmology and Endovascular Surgery, Syzganov National Scientific Center of Surgery, Almaty 050004, Kazakhstan.

Insights

Atrial fibrillation (AF) ablation alters inflammatory cytokines like IL-6 and IL-17A over time. Cytokine levels differ based on AF type and recurrence, suggesting immune monitoring may aid AF management.

Area of Science:

  • Cardiology
  • Immunology
  • Biochemistry

Background:

  • Atrial fibrillation (AF) is a prevalent cardiac arrhythmia globally.
  • Inflammatory cytokines are increasingly linked to AF development, persistence, and recurrence post-ablation.
  • Prospective perioperative cytokine data from Central Asia are limited.

Purpose of the Study:

  • To investigate temporal changes in serum cytokines among AF patients undergoing catheter ablation.
  • To compare cytokine profiles based on AF type and recurrence status post-ablation.
  • To explore the role of cytokines in AF pathogenesis and management.

Main Methods:

  • Prospective observational study involving 166 AF patients in Kazakhstan.
  • Serum cytokine levels (IL-1β, IL-6, IL-17A, IL-1α, IL-28A) measured by ELISA at baseline, immediately post-ablation, and at 6 months.
  • Statistical analysis included Friedman, Wilcoxon signed-rank, Mann-Whitney U, and Kruskal-Wallis tests.

Main Results:

  • Significant temporal changes observed in IL-1β, IL-6, and IL-17A (p < 0.001).
  • IL-6 initially increased post-ablation then decreased below baseline at 6 months; IL-17A showed progressive decline.
  • At 6 months, IL-1α was higher in primary AF versus recurrent AF (p = 0.047); baseline IL-1β and IL-28A differed by AF subtype (p = 0.040, p = 0.014).

Conclusions:

  • Catheter ablation for AF induces distinct temporal changes in key inflammatory cytokines.
  • Cytokine profiles vary significantly with AF type and recurrence, indicating potential for immune monitoring.
  • Findings are exploratory and hypothesis-generating, suggesting further research into immune modulation for AF management.